MapLight Therapeutics, Inc. (MPLT) Free cash flow 2024–2025
MapLight Therapeutics, Inc. (MPLT) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$138.6MFY2025 · since FY2024: -$79.6M → -$138.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$138.6M | -74.2% |
| FY2024 | -$79.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More MPLT financial trends
MPLT RevenueMPLT Net incomeMPLT Net marginMPLT Gross profitMPLT Gross marginMPLT Operating incomeMPLT Operating marginMPLT Operating cash flowMPLT Capital expendituresMPLT Return on equityMPLT Stock buybacksMPLT Dividends paidMPLT Total assetsMPLT Total liabilitiesMPLT Shareholders’ equityMPLT overview →